Hims & Hers Health vs PTC Therapeutics

Hims & Hers Health (HIMS), health care, and PTC Therapeutics (PTCT), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

PTC Therapeutics is worth $5B on the stock market and Hims & Hers Health $4.1B: PTC Therapeutics is valued at 23% more. Hims & Hers Health's operating margin in its latest fiscal year was 4.50% and PTC Therapeutics's 50.1%. Over the past year Hims & Hers Health's share price has moved -48.8% and PTC Therapeutics's -20.5%.

Key facts

Hims & Hers Health market value
$4.1B
PTC Therapeutics market value
$5B
Hims & Hers Health revenue
$2.3BFY to 2025-12-31
PTC Therapeutics revenue
$1.7BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

Hims & Hers Health vs PTC Therapeutics: every measure side by side
Measure Hims & Hers Health PTC Therapeutics
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$4.1Blower$5Bhigher
Revenue$2.3Bhigher$1.7Blower
Earnings$128.4Mlower$682.6Mhigher
Employees2,442higher991lower
Total assets$2.2Blower$2.9Bhigher
Valuation
P/E——
P/S1.8lower2.9higher
P/B11.6—
Dividend yield0.00%0.00%
Profitability
Operating margin4.50%lower50.1%higher
Balance sheet
Net assets$540.9Mhigher-$205.3Mlower
Total liabilities$1.6Blower$3.1Bhigher
Total debt——
Cash on hand$228.6Mlower$984.6Mhigher
Price change
Today-5.44%lower-1.00%higher
1 year-48.8%lower-20.5%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Hims & Hers Health only (0)

None of the tracked investors.

PTC Therapeutics only (1)

Percentages are each holding's share of that investor's reported portfolio. · Who owns PTCT

Further comparisons

Learn

Questions and answers

Which is bigger, Hims & Hers Health or PTC Therapeutics?

By market value, PTC Therapeutics is the larger: $5B against $4.1B for Hims & Hers Health. By revenue in its latest fiscal year, Hims & Hers Health is the larger: $2.3B against $1.7B for PTC Therapeutics.

Which has the higher operating margin?

PTC Therapeutics: 50.1%, against 4.50% for Hims & Hers Health. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which superinvestors own both Hims & Hers Health and PTC Therapeutics?

None of the tracked superinvestors holds both in their latest 13F filing. 0 hold Hims & Hers Health and 1 holds PTC Therapeutics.

Cite this page

Funkfolio, “Hims & Hers Health vs PTC Therapeutics”, data as of 18 November 2026. https://funkfolio.com/compare/hims-vs-ptct

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.